{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-280337","form_type":"8-K","ticker":"CNTA","cik":"0001847903","company_name":"Centessa Pharmaceuticals plc","filed_at":"2026-06-24T12:56:30+00:00","discovered_at":"2026-06-24T13:00:11.894292+00:00","generated_at":"2026-06-24T13:00:23.216113+00:00","sec_items":["1.02","2.01","3.01","3.03","5.01","5.02","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Centessa acquired by Eli Lilly for $38/sh plus up to $9/sh CVR","bullets":["Acquisition closed June 24, 2026; Centessa became wholly owned subsidiary of Lilly.","Shareholders received $38.00 cash per share plus one CVR worth up to $9.00 on milestones.","All outstanding equity awards cashed out based on $38.00 consideration; CVRs issued.","Centessa terminated its Oxford Finance loan facility and Leerink ATM sales agreement.","CEO, board, and other officers resigned; Christopher Stokes and Kristina Wright appointed directors."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-280337","json":"https://secwatch.observer/filing/0001193125-26-280337.json","markdown":"https://secwatch.observer/filing/0001193125-26-280337.md","text":"https://secwatch.observer/filing/0001193125-26-280337.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/0001193125-26-280337-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/d150381d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T13:00:23.216113+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"181b23e4f2","claim":"Samarth Kulkarni departed as Director at Centessa Pharmaceuticals plc.","evidence_excerpt":"each of Francesco De Rubertis, Mario Alberto Accardi, Arjun Goyal, Mary Lynne Hedley, Mathias Hukkelhoven, Samarth Kulkarni, Carol Stuckley and Brett Zbar ceased serving as a member of the board of directors of Centessa","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/0001193125-26-280337-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased serving"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"1e818e8bc6","claim":"Mary Lynne Hedley departed as Director at Centessa Pharmaceuticals plc.","evidence_excerpt":"each of Francesco De Rubertis, Mario Alberto Accardi, Arjun Goyal, Mary Lynne Hedley, Mathias Hukkelhoven, Samarth Kulkarni, Carol Stuckley and Brett Zbar ceased serving as a member of the board of directors of Centessa","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/0001193125-26-280337-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased serving"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"28428683e8","claim":"Raphael Deferiere departed as Executive Officer at Centessa Pharmaceuticals plc.","evidence_excerpt":"Mario Alberto Accardi, Ph.D. (Chief Executive Officer and Director), John Crowley, Stephen Kanes, M.D., Ph.D., and Raphael Deferiere ceased to serve in their capacities as executive officers of Centessa.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/0001193125-26-280337-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased to serve"},{"label":"Role","value":"Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"2eccf3ab30","claim":"Christopher Stokes was appointed as Director at Centessa Pharmaceuticals plc.","evidence_excerpt":"Christopher Stokes and Kristina Mignon Wright were appointed as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/0001193125-26-280337-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"4397b39df7","claim":"Mathias Hukkelhoven departed as Director at Centessa Pharmaceuticals plc.","evidence_excerpt":"each of Francesco De Rubertis, Mario Alberto Accardi, Arjun Goyal, Mary Lynne Hedley, Mathias Hukkelhoven, Samarth Kulkarni, Carol Stuckley and Brett Zbar ceased serving as a member of the board of directors of Centessa","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/0001193125-26-280337-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased serving"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"4ee50e5c6d","claim":"John Crowley departed as Executive Officer at Centessa Pharmaceuticals plc.","evidence_excerpt":"Mario Alberto Accardi, Ph.D. (Chief Executive Officer and Director), John Crowley, Stephen Kanes, M.D., Ph.D., and Raphael Deferiere ceased to serve in their capacities as executive officers of Centessa.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/0001193125-26-280337-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased to serve"},{"label":"Role","value":"Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"850868e8b5","claim":"Mario Alberto Accardi departed as Chief Executive Officer and Director at Centessa Pharmaceuticals plc.","evidence_excerpt":"Mario Alberto Accardi, Ph.D. (Chief Executive Officer and Director), John Crowley, Stephen Kanes, M.D., Ph.D., and Raphael Deferiere ceased to serve in their capacities as executive officers of Centessa.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/0001193125-26-280337-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased to serve"},{"label":"Role","value":"Chief Executive Officer and Director"}],"fact_type":"executive_change"},{"claim_id":"9fa81293c3","claim":"Francesco De Rubertis departed as Director at Centessa Pharmaceuticals plc.","evidence_excerpt":"each of Francesco De Rubertis, Mario Alberto Accardi, Arjun Goyal, Mary Lynne Hedley, Mathias Hukkelhoven, Samarth Kulkarni, Carol Stuckley and Brett Zbar ceased serving as a member of the board of directors of Centessa","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/0001193125-26-280337-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased serving"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"a76123f6e1","claim":"Stephen Kanes departed as Executive Officer at Centessa Pharmaceuticals plc.","evidence_excerpt":"Mario Alberto Accardi, Ph.D. (Chief Executive Officer and Director), John Crowley, Stephen Kanes, M.D., Ph.D., and Raphael Deferiere ceased to serve in their capacities as executive officers of Centessa.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/0001193125-26-280337-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased to serve"},{"label":"Role","value":"Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"b3a3a81f37","claim":"Arjun Goyal departed as Director at Centessa Pharmaceuticals plc.","evidence_excerpt":"each of Francesco De Rubertis, Mario Alberto Accardi, Arjun Goyal, Mary Lynne Hedley, Mathias Hukkelhoven, Samarth Kulkarni, Carol Stuckley and Brett Zbar ceased serving as a member of the board of directors of Centessa","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/0001193125-26-280337-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased serving"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"c0f84825cc","claim":"Brett Zbar departed as Director at Centessa Pharmaceuticals plc.","evidence_excerpt":"each of Francesco De Rubertis, Mario Alberto Accardi, Arjun Goyal, Mary Lynne Hedley, Mathias Hukkelhoven, Samarth Kulkarni, Carol Stuckley and Brett Zbar ceased serving as a member of the board of directors of Centessa","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/0001193125-26-280337-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased serving"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"c3260daa14","claim":"Kristina Mignon Wright was appointed as Director at Centessa Pharmaceuticals plc.","evidence_excerpt":"Christopher Stokes and Kristina Mignon Wright were appointed as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/0001193125-26-280337-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"e8eed3d522","claim":"Carol Stuckley departed as Director at Centessa Pharmaceuticals plc.","evidence_excerpt":"each of Francesco De Rubertis, Mario Alberto Accardi, Arjun Goyal, Mary Lynne Hedley, Mathias Hukkelhoven, Samarth Kulkarni, Carol Stuckley and Brett Zbar ceased serving as a member of the board of directors of Centessa","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847903/000119312526280337/0001193125-26-280337-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased serving"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}